PLX- Protalix Biotherapeutics, Inc.

Name: Protalix Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Protalix Biotherapeutics, Inc. (PLX) has 9 insiders with recent SEC Form 4 filings, including 8 buys and 4 sells. PLX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
VP	Naos Yaron	225.8K	$487.8K	-
CEO	Bashan Dror	188.5K	$407.2K	-
Dir	Ben Zvi Shmuel	7.5K	$16.2K	-
Dir	Schwartz Aharon	7.5K	$16.2K	-
Dir	Boudes Pol F	7.5K	$16.2K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 19, 2025	Bashan Dror56	President And CEO	Buy	56,000	$1.81	$101,360.00	+42.3%	+28.9%	-
Nov 18, 2025	Bar-Shalev Amos	Director	Sell	168	$1.87	$314.16	-100%	+58.5%	-
Jun 10, 2025	Schwartz Aharon	Director	Buy	129,000	$1.60	$205,884.00	+74.1%	0.0%	+25.9%
Oct 19, 2023	Bashan Dror56	President And CEO	Buy	64,516	$1.40	$90,483.69	+35.0%	+5.5%	-25.3%
Jan 3, 2023	Schwartz Aharon	Director	Buy	110,000	$1.42	$155,815.00	+171.9%	+61.3%	+30.7%
Apr 11, 2022	Bashan Dror56	President And CEO	Buy	68,000	$1.50	$102,000.00	New	-21.6%	+66.7%
Jun 3, 2021	Dexcel Pharma Technologies Ltd.79	10% Owner	Sell	918,717	$2.27	$2,088,857.27	-10.2%	-28.4%	-44.1%
Apr 7, 2020	Schwartz Aharon	Director	Buy	64,000	$2.43	$155,264.00	New	-	-
May 16, 2017	Manor Moshe	President &CEO	Buy	50,000	$0.81	$40,500.00	New	-	-
Dec 2, 2016	Camber Capital Management LLC	10% Owner	Sell	2,500,000	$0.32	$792,000.00	-18.8%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC